24% in primary kidney outcome 29% in cardiovascular death 20% in all-cause mortality Read the full study here: nejm.org/doi/full/10.10 #MedTwitter #KidneyHealth #DiabetesResearch #HealthcareInnovation New @NEJM study reveals #Semaglutide (#Ozempic) significantly reduces risks of major kidney events, cardiovascular outcomes, and mortality in patients with type 2 #diabetes and chronic kidney disease
If you suddenly stop taking sertraline, you may experience withdrawal symptoms such as nausea, sweating, depression, mood changes, frenzied or abnormally excited mood, irritability, anxiety, confusion, dizziness, headache, tiredness, seizures, ringing in the ears, numbness or tingling in the arms, legs, hands, or feet, difficulty falling asleep or staying asleep
Off-label use of drugs is both common and legal
JS Park, JH Chyun, YK Kim, LL Line, BP Chew
Skin whitening ingredients work in the following ways